Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly's Cure For Heartbreak
Yahoo/Investors Business Daily
Tuesday, June 2, 2009 - 10:27pm
tags:
Eli Lilly
Skin-Cancer Drug Uses Genetics
WSJ Online
Tuesday, June 2, 2009 - 10:25pm
tags:
skin cancer, genetics, Roche, BRAF inhibitor
New Valeant CEO Finds That Focus Puts More Drugs Into The Pipeline
Yahoo/Investors Business Daily
Tuesday, June 2, 2009 - 10:23pm
tags:
Valeant Pharmaceuticals, pipelines
Par Pharma launched generic Risperdal M-Tab
Yahoo/AP
Tuesday, June 2, 2009 - 10:21pm
tags:
Par Pharmaceutical, generics, Risperdal
ASCO's Big Winner
Motley Fool
Tuesday, June 2, 2009 - 5:43pm
tags:
ASCO, Cougar Biotechnology, Big Pharma, Pfizer, Celldex, Genentech, Cellgene
Why We're Cautious on The Medicines Company
Seeking Alpha
Tuesday, June 2, 2009 - 5:42pm
tags:
Medicines Company
FDA Tries to Decide What Should, Shouldn’t Be Kept Secret
WSJ Online
Tuesday, June 2, 2009 - 5:41pm
tags:
FDA
Judge Allows Cafepharma Posts In Schering Vytorin Lawsuit
CNN Money
Tuesday, June 2, 2009 - 5:40pm
tags:
cafepharma, Schering Plough, Vytorin
GSK in final trial of vaccine to fight malaria
The Times,UK
Tuesday, June 2, 2009 - 9:06am
tags:
GSK, malaria, vaccines, drug trials
Drug-Maker Pens Are Endangered Species at Cancer Confab
WSJ Online
Tuesday, June 2, 2009 - 9:04am
tags:
ASCO, physican gifts
Genzyme completes cancer drug rights deal worth up to $1.25 billion to Bayer
Yahoo/AP
Tuesday, June 2, 2009 - 8:40am
tags:
Bayer, cancer, Genzyme, Campath
Ahead of the Bell: Medicis, Obagi downgraded
Yahoo/AP
Tuesday, June 2, 2009 - 8:37am
tags:
Medicis, Obagi Medical Products
Merck and AstraZeneca: Not the Kind of Deal That Happens Very Often
Seeking Alpha
Tuesday, June 2, 2009 - 8:26am
tags:
Merck, AstraZeneca
Vertex: Long Term Buy Opportunity
Seeking Alpha
Tuesday, June 2, 2009 - 8:14am
tags:
Vertex Pharmaceuticals, Telaprevir
Federal Court reduces Medtronic's payment in damages to J&J unit in patent dispute
Yahoo/AP
Tuesday, June 2, 2009 - 8:12am
tags:
JNJ, Medtronic, patents
ChemGenex Says Drug Rids Leukemia in Some Patients
Bloomberg
Tuesday, June 2, 2009 - 7:15am
tags:
ChemGenex, leukemia
Heart drug from Nuvelo buyer rejected
Bizjournals.com
Tuesday, June 2, 2009 - 7:14am
tags:
Nuvelo, ARCA biopharma, Gencaro
GlaxoSmithKline signs potential $1 billion deal with US biotech company Concert
Yahoo/AP
Tuesday, June 2, 2009 - 7:14am
tags:
GSK, Concert Pharmaceuticals, partnerships
Drug Stocks That Are Under the Radar
Seeking Alpha
Tuesday, June 2, 2009 - 7:13am
tags:
JNJ, Merck, Novartis, Pfizer, Sanofi, Roche
Takeda's Millennium Looking For Deals To Bolster Pipeline
WSJ Online
Monday, June 1, 2009 - 11:10pm
tags:
Takeda, Millennium, pipelines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.